[1] Krawitt EL. Autoimmune hepatitis. N Engl J Med,2006,354(1):54-66.
[2] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 中华肝脏病杂志 , 2015, 23(11): 810-819.
[3] Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standars treatment and systematic review of alternative treatments.World J Gastroenterol,2017,23(33):6030-6048.
[4] Suzuli Y, Arase Y,??Ikeda K, et al. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome.J Gstroenterol Hepatol,2004,19(6):699-706.
[5] 张敏,韩涛. 血清 IgG4 检测在 IgG4 相关性疾病诊治中的作用. 中华肝脏病杂志,2013,21(9): 715-717.
[6] Chazouillères O, Wendum D, Serfaty L, et al.Primary biliary cirrhosis－autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology,1998,28 (2): 296-301.
[7] European Association for the Study of the Liver.EASL clinical practice guidelines:Management of cholestatic liver diseases. J Hepatal,2009,51(2):237-267.
[8] Floreani A Rizzotto ER,Ferrara F,et al.Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.Am J Gastroenterol,2005,100(7):1516-1522.
[9] European Association for the Study of the Liver.EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol,2017,67 (1): 145-172.
[10] Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology,2009,50(1) : 291-308. |
